Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
2012
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
30
Citations
NaN
KQI